Search clinical trials for: 18F-DPA-714 PET/CT neuroimaging

Total 484 results

M.D. Anderson Cancer Center
GE Healthcare

Withdrawn

A Pilot, Exploratory, Non-Randomized Study of PET/CT With the Investigational Agent [18F] Fluciclatide to Correlate With Response to Anti-Cancer Therapy

Advanced Cancers
University Hospital, Caen

Completed

Performance of PET 18 F-FDG Coupled to CT With Contrast Injection Iodized in the Diagnosis of Early Recurrences of Head and Neck Carcinoma Treated With Concurrent Chemoradiation. Comparison With 18F-FDG PET Coupled With CT Not Injected With Filling CT Standard Injection (TEPVAD)

Squamous Cell Carcinoma of the Head and Neck

France
Washington University School of Medicine

Recruiting

Immune Checkpoint Blockade Therapy Using 18F-FLT PET/CT

Cancer

United States
Sichuan Provincial People's Hospital

Recruiting

[18F]AlF-NOTA-pentixather PET/CT in Patients With Suspected Primary Hyperaldosteronism

Aldosterone-Producing Adenoma

China
Institut Cancerologie de l'Ouest

Recruiting

Detection and Metabolic Characterization in DOPA PET/CT of Brain Metastases (DOPACER)

MRI | Brain Metastases

France
Nantes University Hospital

Completed

Assessment of Osteoblastic Activity With 18F-Fluoride in Aortic Bioprosthesis Structural Valve Dysfunction (SVD) (TEP-SVD)

Aortic Bioprosthesis Structural Valve Dysfunction

France
University of Lausanne Hospitals

Completed

Ga-68-NODAGA-MJ9 Compared to F-18-FCH PET/CT for Prostate Cancer Patients

Prostate Cancer

Switzerland
Buddhist Tzu Chi General Hospital

Completed

18F-fluorocholine PET/CT for Hyperparathyroidism

Hyperparathyroidism

Taiwan
The First Affiliated Hospital of Xiamen University

Recruiting

68Ga-FAPI-LM3 PET/CT Imaging in Patients With FAP/SSTR2 Positive Disease and Compared With 18F-FDG

Positron-Emission Tomography | FAP | SSTR2

China
Rigshospitalet, Denmark

Completed

18F-ASIS PET/CT Imaging of Tissue Factor Expression In Patients With Primary and Metastastic Cancer

Breast Cancer | Pancreatic Cancer | Ovarian Cancer | Lung Cancer | Cervix Cancer

Denmark
Columbia University
National Center for Research Resources (NCRR)

Terminated

Use of PET Imaging to Distinguish Malignant From Benign IPMN

Pancreatic Cancer | Neoplasm

United States
OHSU Knight Cancer Institute
Oregon Health and Science University; Progenics Pharmaceuticals, Inc.

Not yet recruiting

Evaluation of the Change in PSMA Expression in Prostate Cancer in Response to Hormonal Therapy

Prostate Adenocarcinoma | Castration Resistant Prostate Cancer | Castration Sensitive Prostate Cancer

United States
Washington University School of Medicine

Terminated

18F-FLT PET Imaging in Patients With Advanced Melanoma

Melanoma

United States
Ruijin Hospital

Recruiting

Prediction of Neoadjuvant Chemotherapy Efficacy in Locally Advanced Gastric Cancer

Gastric Cancer

China
Peking Union Medical College Hospital

Unknown

68Ga-FAPI-04 and 18F-FDG PET/CT in Patients With Epithelial Ovarian Cancer: Compared With Histological Findings

Epithelial Ovarian Cancer

China
Central Hospital, Nancy, France

Completed

Evaluation of a Metabolic Preparation by a Low-carbohydrate Diet as Atkins-diet to Help in Detecting Infective Endocarditis by 18F-FDG PET (TEPEIR)

Infective Endocarditis

France
Medhat Osman
Blue Earth Diagnostics

Completed

Prostate Cancer Patients With Biochemical Recurrence

Patients With Prostate Cancer

United States
Alan Nichol

Completed

Positron Emission Tomography (PET) With 3,4-dihydroxy-6-18F-fluoro-L-enylalanine (18F-FDOPA) Study

Cancer (High-grace Glioma)

Canada
University Hospital, Caen
CNRS, UMR ISTCT 6301, LDM-TEP Groupe, GIP Cyceron, Caen, France

Completed

Dosimetry and Biodistribution of [18F]-Fludarabine in Lymphoid Malignancies (FLUDATEP)

Untreated B-Chronic Lymphocytic Leukemia or Diffuse Large B Cells Lymphoma Patients

France
University of Utah

Terminated

Assessment of Primary and Metastatic Brain Tumor Hypoxia With Fluoromisonidazole, FDG and Water

Brain Cancer

United States
British Columbia Cancer Agency

Recruiting

DOTATOC PET/CT for Imaging NET Patients

Pituitary Adenoma | Neuroendocrine Tumors | Medulloblastoma | Small-cell Lung Cancer | Neuroblastoma | Meningioma | Merkel Cell Carcinoma | Pheochromocytoma | Paraganglioma | Gastrinoma | Glucagonoma | Insulinoma | Vipoma | Carcinoid | Ganglioneuroma | Medullary Carcinoma

Canada
British Columbia Cancer Agency
Carraressi Foundation OVCARE

Terminated

Imaging Tumor Hypoxia With 18F-EF5 PET in Recurrent or Metastatic Clear Cell Ovarian Cancer

Ovarian Neoplasms | Ovarian Cancer

Canada
Seoul St. Mary's Hospital

Unknown

18F-NaF Uptake and Aortic Stenosis Progression

Aortic Stenosis
Merck Sharp & Dohme LLC

Terminated

A Study to Evaluate [18F]-FDG PET (Fluorodeoxyglucose-positron) in Patients With Pancreatic Cancer (MK-0000-144)

Advanced Pancreatic Adenocarcinoma
Peking University Cancer Hospital & Institute

Recruiting

Positron Nuclide Labeled DOTA-FAPI PET Study in Colocrectal Cancer

Colorectal Cancer | Positron-Emission Tomography | Tumor, Solid

China
University of Arizona
Blue Earth Diagnostics; Banner University Medical Center

Completed

Fluciclovine-PET/CT for Bone Metastases From Prostate Adenocarcinoma (BoneMetPETCT)

Prostate Adenocarcinoma

United States
Memorial Sloan Kettering Cancer Center

Active, not recruiting

Positron Lymphography Via Intracervical 18F-FDG Injection for Pre-surgical Lymphatic Mapping in Stage IB1 Cervical Cancer and High-grade Endometrial Cancer

Cervical Cancer | Endometrial Cancer

United States
University of Utah

Active, not recruiting

Amyloid Plaque Deposition in Chemotherapy-Induced Cognitive Impairment

Breast Cancer

United States
University of Aarhus

Recruiting

A Head-to-head Comparison of MRI, CT, 18F-FDGal and 18F-choline in Patients With Hepatocellular Carcinoma

Hepatocellular Carcinoma

Denmark
Memorial Sloan Kettering Cancer Center
Progenics Pharmaceuticals, Inc.

Active, not recruiting

Prostate-Specific Membrane Antigen (PSMA) PET Scans in People Prostate Cancer

Prostate Cancer | Metastatic Prostate Cancer | Prostate Adenocarcinoma | Prostate Cancer Metastatic | Prostate Neoplasm

United States
Universitaire Ziekenhuizen KU Leuven

Completed

Synaptic Density and Progression of Parkinson's Disease.

Parkinson Disease

Belgium
Queen's Medical Center
National Cancer Institute (NCI); National Institutes of Health (NIH)

Completed

Chemotherapy Response Monitoring With 18F-choline PET/CT in Hormone Refractory Prostate Cancer

Hormone Refractory Prostate Cancer

United States
Nanjing Medical University

Unknown

Individualized Precise Radiotherapy With the Guidance of Radiosensitivity of Locally Advanced Cervical Cancer (PROGRAMMA)

Cervical Cancer

China
British Columbia Cancer Agency

Approved for marketing

18F-FDG PET Imaging in Cardiac Sarcoidosis

Cardiac Sarcoidosis

Canada
Sun Yat-sen University

Completed

Combining PET/CT and EBV DNA to Evaluate the Hazard of Progression in the Follow-up of Locally Advanced NPC

Nasopharyngeal Carcinoma

China
National Cancer Institute (NCI)

Recruiting

18F-Fluciclovine PET/CT in Multiple Myeloma

Multiple Myeloma | Relapsed and/or Refractory Multiple Myeloma (RRMM) | Newly Diagnosed Multiple Myeloma (NDMM)

United States
Sir Mortimer B. Davis - Jewish General Hospital

Enrolling by invitation

Fluorocholine PET/CT Basket Trial

Fluorocholine PET/CT

Canada
The Netherlands Cancer Institute
Noordwest Ziekenhuisgroep

Recruiting

FAPI PET/CT for Lymph Node Staging in Colorectal Carcinoma (FAPI-CRC1)

Colorectal Cancer

Netherlands
Medical University of Vienna

Not yet recruiting

Organ Interaction Patterns in Healthy Individuals for Improved PET/CT Diagnostics (Healthy-PET)

Healthy
Memorial Sloan Kettering Cancer Center

Completed

PET Imaging of Cancer Patients Using [18F]-SKI-249380, a Radiolabeled Dasatinib-Derivative

Melanoma | Sarcoma | Lymphoma | Carcinoma | Myeloma

United States
First Affiliated Hospital Xi'an Jiaotong University

Not yet recruiting

Study of 18F-FAPI Applied to Gastrointestinal Cancer

Gastrointestinal Cancer
Cancer Institute and Hospital, Chinese Academy...

Recruiting

Application of 18F-PSMA PET / CT Imaging in Prostate Specific Membrane Antigen Positive Tumor

Malignancy

China
Celal Bayar University

Completed

The Role of 68GA DOTATATE PET/CT In Breast Cancer Imaging

Breast Cancer

Turkey
Stanford University

Completed

The Role of Audiovisual Biofeedback on Image Quality During 4D Anatomic and Functional Imaging

Lung Cancer

United States
Michael C Roarke, MD

Completed

Comparison of F-18 FDG and C-11 Acetate PET in Multiple Myeloma

Multiple Myeloma

United States
Case Comprehensive Cancer Center

Completed

18F-Fluciclovine PET to Distinguish Tumor Progression From Radiation Necrosis

Secondary Malignant Neoplasm of Brain and Cerebral Meninges

United States
Asan Medical Center

Terminated

F-18 FDOPA PET/CT Versus I-123 MIBG Scintigraphy With SPECT/CT for the Diagnosis of Pheochromocytoma and Paraganglioma

Pheochromocytoma | Paraganglioma

Korea, Republic of
The First Affiliated Hospital of Xiamen University

Recruiting

Evaluating the Potential Usefulness of 18F-AlF-FAPI PET/CT in Patients With Gastrointestinal Tumors and Compared With 18F-FDG PET/CT

Gastric Cancer | Pancreatic Cancer | Liver Cancer

China
National Cancer Institute (NCI)

Withdrawn

18F FLT Imaging Studies of Treatment Response for Lung Cancer and Thymoma

Carcinoma, Non-Small-Cell Lung | Thymus Neoplasms
Robert Flavell, MD, PhD
National Cancer Institute (NCI)

Recruiting

Imaging Study of [89Zr]DFO-YS5 for Detecting CD46 Positive Malignancy in Multiple Myeloma

Multiple Myeloma | Plasma Cell Myeloma

United States

Search clinical trials for: 18F-DPA-714 PET/CT neuroimaging

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ukraine

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations